UNSPSC 51372002: Alletorphine

This classification denotes an opioid receptor agonist with the molecular formula C27H35NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4UWR086NOA, chemically known as 6,14-ethenotetrahydrooripavine, 17-allyl-17-demethyl-7alpha-((r)-1-hydroxy-1-methylbutyl)- but generally known as alletorphine, which bears US NIH Compound Identifier 72090. European Medicines Agency schedules Alletorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05333MIG.

UNSPSC 51372002 Alletorphine is a Commodity code for pharmaceutical products used in emergency medical response and opioid overdose management. State and local governments procure naloxone (a fast-acting opioid antagonist), safe drug deactivation systems, and related emergency medical supplies under this code to support community health initiatives, public health departments, emergency response services, and addiction treatment programs. The work involves recurring purchase of finished pharmaceutical products and allied systems with standardized delivery schedules and compliance requirements tied to drug administration, storage, and disposal protocols.

Solicitation activity under the code spans county health departments and special-purpose health districts. Seminole County, Florida released an IFB (Solicitation Number IFB60459723LAS) in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option and was potentially funded through FEMA, introducing federal compliance overlays including the Clean Air Act and Federal Water Pollution Control Act. Vendors must provide unit pricing, maintain workers' compensation and commercial general liability insurance, pass E-Verify verification, and meet drug-free workplace certification requirements. The procurement does not specify set-aside designations for disadvantaged enterprises.